SCHEMBL23795271

SCHEMBL23795271

CC(O)(CC(C)(c1ccccc1)c1ccccc1)c1ccccc1

nearest known ligand 0.44

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
CYP2C19 P33261 4/20 0.44
HIF1A Q16665 1/20 0.42
ALDH1A1 P00352 3/20 0.41
TAAR1 Q96RJ0 1/20 0.41
ALOX15 P16050 1/20 0.41
ESR2 Q92731 7/20 0.40
ESR1 P03372 3/20 0.40
CYP3A4 P08684 1/20 0.40
CYP1A2 P05177 1/20 0.40
CYP2C9 P11712 1/20 0.40
MAPK1 P28482 1/20 0.39
KMT2A Q03164 2/20 0.39
MAPT P10636 1/20 0.39
SMN1; SMN2 Q16637 1/20 0.38
CYP2D6 P10635 1/20 0.37
HSD17B10 Q99714 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23795282 0.89 KMT2A (0.51) CYP2C19HIF1AALDH1A1ALOX15MAPK1
SCHEMBL23795276 0.89 KMT2A (0.51) CYP2C19HIF1AALDH1A1ALOX15MAPK1
SCHEMBL3197683 0.88 CYP2C19 (0.48) CYP2C19HIF1AALDH1A1TAAR1ALOX15
SCHEMBL27367620 0.84 CYP2C19 (0.46) CYP2C19HIF1AALDH1A1TAAR1ALOX15
SCHEMBL8408194 0.84 CYP2C19 (0.43) CYP2C19HIF1AALDH1A1TAAR1ALOX15
SCHEMBL9426119 0.84 CYP2C19 (0.43) CYP2C19HIF1AALDH1A1TAAR1ALOX15
SCHEMBL17899832 0.80 CYP2C19 (0.43) CYP2C19HIF1AALDH1A1TAAR1ALOX15
SCHEMBL11045361 0.80 CYP2C19 (0.43) CYP2C19HIF1AALDH1A1TAAR1ALOX15
SCHEMBL27919061 0.78 TAAR1 (0.46) CYP2C19HIF1AALDH1A1TAAR1ALOX15
SCHEMBL3190736 0.78 CYP2C19 (0.48) CYP2C19HIF1AALDH1A1TAAR1ALOX15

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12127473-B2 Di-, tri- and tetraphenylindane derivates and their use in organic electronics DOTTIKON ES HOLDING AG (CH) 2024-10-22 US disclosed
US-20220006020-A1 DI-, TRI- AND TETRAPHENYLINDANE DERIVATES AND THEIR USE IN ORGANIC ELECTRONICS DOTTIKON ES HOLDING AG (CH) 2022-01-06 US disclosed
EP-3877357-A1 DI-, TRI- AND TETRAPHENYLINDANE DERIVATIVES AND THEIR USE IN ORGANIC ELECTRONICS DOTTIKON ES HOLDING AG (CH) 2021-09-15 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220006020-A1 DI-, TRI- AND TETRAPHENYLINDANE DERIVATES AND THEIR USE IN ORGANIC ELECTRONICS NR0B2, KCNJ2, TRRAP CYP2C19 3033/4885HIF1A 4646/4885ALDH1A1 2569/4885
US-12127473-B2 Di-, tri- and tetraphenylindane derivates and their use in organic electronics NR0B2, KCNJ2, TRRAP CYP2C19 3033/4885HIF1A 4646/4885ALDH1A1 2569/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.